|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 250.13 USD | -2.50% |
|
+0.73% | +9.40% |
| 09:43pm | ResMed Receives FDA Clearance for AI-Powered Device to Personalize Sleep Apnea Therapy | MT |
| 05/12 | Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing | MT |
| Capitalization | 3.74TCr 3.22TCr 3.02TCr 2.81TCr 5.18TCr 3,37100Cr 5.65TCr 35TCr 14TCr 1,59200Cr 14TCr 14TCr 5,83100Cr | P/E ratio 2026 * |
24.5x | P/E ratio 2027 * | 22.1x |
|---|---|---|---|---|---|
| Enterprise value | 3.62TCr 3.11TCr 2.92TCr 2.72TCr 5.01TCr 3,26000Cr 5.46TCr 34TCr 13TCr 1,53900Cr 14TCr 13TCr 5,63900Cr | EV / Sales 2026 * |
6.45x | EV / Sales 2027 * | 5.86x |
| Free-Float |
76.64% | Yield 2026 * |
0.94% | Yield 2027 * | 1.04% |
Last Transcript: ResMed, Inc.
| 1 day | -2.50% | ||
| 1 week | +0.73% | ||
| Current month | -2.20% | ||
| 1 month | +0.04% | ||
| 3 months | -10.47% | ||
| 6 months | -0.31% | ||
| Current year | +9.40% |
| 1 week | 248.75 |  | 257.98 |
| 1 month | 237.62 | | 258.09 |
| Current year | 199.92 | | 293.81 |
| 1 year | 199.92 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 50.77 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 52 | 01/03/2013 |
Brett Sandercock
DFI | Director of Finance/CFO | 58 | 01/01/2006 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 77 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 52 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 82 | 01/06/1989 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.09% | 26 M€ | +11.85% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.50% | +0.73% | +2.22% | +12.45% | 3.74TCr | |
| -0.93% | -2.92% | +5.74% | +0.02% | 22TCr | |
| -1.49% | -0.14% | +5.15% | +108.29% | 20TCr | |
| -1.10% | -0.14% | -5.12% | -17.66% | 16TCr | |
| -4.13% | -7.20% | +5.65% | +102.36% | 14TCr | |
| -0.23% | +1.93% | -17.09% | -12.20% | 5.65TCr | |
| -2.04% | -0.88% | +19.21% | +16.61% | 5TCr | |
| -2.02% | -5.06% | -1.03% | -8.81% | 4.12TCr | |
| -2.46% | +5.29% | +1.87% | - | 3.89TCr | |
| -1.16% | -1.94% | -23.88% | -36.11% | 3.46TCr | |
| Average | -1.84% | -0.43% | -0.73% | +18.33% | 9.82TCr | |
| Weighted average by Cap. | -1.77% | -1.12% | +1.59% | +35.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 560.24Cr 482.25Cr 452.72Cr 420.84Cr 775.73Cr 51TCr 846.3Cr 5.28TCr 2.04TCr 24TCr 2.1TCr 2.06TCr 87TCr | 601.97Cr 518.18Cr 486.45Cr 452.19Cr 833.51Cr 54TCr 909.34Cr 5.67TCr 2.2TCr 26TCr 2.26TCr 2.21TCr 94TCr |
| Net income | 153.55Cr 132.17Cr 124.08Cr 115.34Cr 212.61Cr 14TCr 231.95Cr 1.45TCr 559.89Cr 6.54TCr 576.28Cr 563.95Cr 24TCr | 170.68Cr 146.92Cr 137.92Cr 128.21Cr 236.33Cr 15TCr 257.83Cr 1.61TCr 622.36Cr 7.26TCr 640.57Cr 626.87Cr 27TCr |
| Net Debt | -123.01Cr -105.89Cr -99Cr -92Cr -170.33Cr -11TCr -185.83Cr -1.16TCr -448.56Cr -5.24TCr -461.68Cr -451.81Cr -19TCr | -209.76Cr -180.56Cr -169.5Cr -157.56Cr -290.43Cr -19TCr -316.86Cr -1.98TCr -764.85Cr -8.93TCr -787.23Cr -770.39Cr -33TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/25/09 | 250.14 $ | -2.50% | 3,88,715 |
| 05/25/05 | 256.55 $ | +2.00% | 7,08,376 |
| 04/25/04 | 251.51 $ | +0.03% | 4,89,063 |
| 03/25/03 | 251.44 $ | +0.24% | 5,49,929 |
| 02/25/02 | 250.85 $ | +0.99% | 10,86,092 |
Delayed Quote Nyse, December 09, 2025 at 01:52 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition